Daelemans Lab

KU Leuven, Rega Institute for Medical Research. Drug target identification and validation, drug discovery, CRISPR screening, nucleocytoplasmic transport.

[Cell Press @CellPressNews]

"TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry"

@BaggenJim, @DaelemansLab, @TheCrick Peter Cherepanov

Read more in @CellCellPress https://t.co/VndCUlxqIJ

[Jim Baggen @BaggenJim]

Check out our review about cellular host factors for SARS-CoV-2 infection, which was just published in @NatureMicrobiol. Thanks to Els Vanstreels, Dirk Daelemans @DaelemansLab and Sander Jansen for their efforts!
https://t.co/U2JHP5cNye

https://t.co/cPFrUM9klt

[Daelemans Lab @DaelemansLab]

#LKI_Oncoforum_2021 Looking forward to giving a tech talk on CRISPR technology at the virtual LKI-oncoforum shortly.

[Nature Genetics @NatureGenet]

🚨NEW CONTENT ALERT!
From @BaggenJim and colleagues: Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2 | https://t.co/UVKU34ITAQ